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‘‘A 20-Year Experience of Mitral Valve Repair with Artificial Chor-
dae in 608 Patients.’’ Discussion by James I. Fann, M.D., Stanford,
CA.
Dr. James I. Fann (Stanford, CA) Loris, I wish to congratulate
you on a comprehensive presentation regarding the use of artificial
chordae replacement in the repair of degenerative mitral valve dis-
ease. Included in your series is isolated anterior or bileaflet prolapse
in nearly half the cases.What is impressive is the number of patients,
the excellent early and late results, and the length and completeness
of followup. It is believed that artificial chordae replacement in de-
generative disease and posterior leaflet prolapse in particular may
provide additional chordal support, maintain greater leaflet area, per-
mit for more complex repair, and has the potential of decreased rate
of failure.
My first question relates to the percentage of patients who had
isolated posterior leaflet prolapse which comprised nearly 50% or
51% of patients who underwent chordal replacement in your group’s
experience. Here is the question. Do you think that a segmental
leaflet resection and reconstruction with annuloplasty without
chordal replacement - do you think that would have been sufficient
in these patients or is chordal replacement absolutely necessary?
Dr. Salvador. Based on Cox regression analysis, we observed
that quadrangular resection of the posterior leaflet is a protective fac-
tor only if associated with artificial chordae implant. Actually, I am
not sure that the results would be the same without artificial chordae.
In the last years, we performed less frequently quadrangular re-
section and in this subgroup any redo was needed. In the first decade
of this series, when resection was widely adopted, it provided excel-
lent results, that made us pretty happy about performance at long-
term follow-up. I don’t know honestly how to explain why resectionThe Journal of Thorais a protective factor. I think that at the beginning of the experience,
without intraoperative TEE we couldn’t precisely analyze mitral
valve pathology. So we performed more quadrangular resections
of the posterior leaflet, the gold standard at that time, than we do
at present. I think that, in future, we will evaluate the long-term re-
sults of this strategy, as more and more patients without resection
will be included in a study.
Dr. Fann. From the surgical perspective, what technique do you
employ to optimize the length or to adjust the chordae. That is, how
do you size the length of the chordae? How do you size the ring for
the mitral valve repair?
Dr. Salvador. Despite many suggestions that you can find in lit-
erature, we always use one simple method. We fill-up the ventricle
with saline once the repair is completed. I mean after implanting the
ring, quadrangular resection, if needed, or commissural fusion and
whatever else you have to repair. At the very end, we fill the ventri-
cle and we decide: to push or pull the leaflet, up or down, until we
obtain a satisfactory coaptation. This is the only method we use. Af-
ter acquiring an adequate experience we do not even pay so much
attention to the length because it becomes something instinctual. I
don’t think is so fundamental to execute scientific measurements
about distance between papillary muscles and annulus or something
like this.
Dr. Fann. Do you oversize the annulus when you do the annu-
loplasty? I know you use the.
Dr. Salvador. Most of our patients had autologous pericardium
band implant and we adopt a very simple way to measure it, using
the Carpentier sizers based on the patient’s Body Surface Area.
We assume that a BSA under 1.60 Square Meters, need the Carpent-
ier’s number 32 and we cut the band around that sizer. Between 1.60
and 1.80 we use a 34 sizer and above 1.80 the 36 sizer.
Dr. Fann. And finally you report that a total of 12 patients with
more than 21MRwere found immediately after surgery. What was
the cause in these patients other than the those patients that you
reported that had SAM that also had 21 MR and how were these
patients treated postoperatively?
Dr. Salvador. Actually, the patients were discharged! Mostly,
this entity of post-operative MR was observed at the beginning of
the experience, however in a small percentage of patients: 12 out
of 608. First of all, I repeat, in the mid ’80, it was difficult to have
the echo in OR. At that time we had only normal transthoracic
echo so we accepted this grade of insufficiency if it was found after
leaving the OR. Right now it is a very rare event that a patient is dis-
charged with such grade of insufficiency and there must be a very
compelling reason. Today, it’s very rare also to be discharged
even with 11. At the beginning of the experience we accepted it,
considering that, in some patients, a second run of cardiopulmonary
bypass would have been more risky than a 21 mitral regurgitation.
Dr. Fann. Loris, thank you very much for an insightful presen-
tation. I appreciate it.
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